The effects of bile acid sequestrants on lipid profile and blood glucose concentrations: A systematic review and meta-analysis of randomized controlled trials

被引:50
作者
Mazidi, Mohsen [1 ,2 ]
Rezaie, Peyman [3 ]
Karimi, Ehsan [3 ]
Kengne, Andre Pascal [4 ,5 ]
机构
[1] Chinese Acad Sci, Inst Genet & Dev Biol, Key State Lab Mol Dev Biol, Beijing, Peoples R China
[2] Univ Chinese Acad Sci IC UCAS, Int Coll, Inst Genet & Dev Biol, West Beichen Rd, Chaoyang, Peoples R China
[3] Mashhad Univ Med Sci, Sch Med, Biochem & Nutr Res Ctr, Mashhad, Iran
[4] South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa
[5] Univ Cape Town, Cape Town, South Africa
关键词
Meta-analysis; Bile acid sequestrants; Fasting blood glucose; Lipid profile; TYPE-2; DIABETES-MELLITUS; IMPROVES GLYCEMIC CONTROL; COLESEVELAM HYDROCHLORIDE; DOUBLE-BLIND; INSULIN-RESISTANCE; LDL CHOLESTEROL; THERAPY; COLESTIMIDE; COMBINATION; HCL;
D O I
10.1016/j.ijcard.2016.10.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To undertake a systematic review andmeta-analysis of prospective clinical studies to determine the effect of bile acid sequestrants (BAS) on lipid profile and blood glucose concentrations. Method: PubMed-Medline, Web of Science, Cochrane Database and Google Scholar databases were searched (up until August 2016) to identify prospective studies evaluating the impact of BASs on the cardio-metabolic profile. Random effects model meta-analysis was used for quantitative data synthesis. Sensitivity analysis was conducted using the leave-one-out method. Heterogeneity was quantitatively assessed using the I-2 index. Systematic review registration: CRD42016035973. Results: From a total of 769 entries identified, 15 studies were included in the final analysis. The meta-analysis indicated a significant reduction in fasting serum triglyceride concentrations following treatment with BASs (weighted mean difference [WMD] 0.54 mg/dL, 95% CI 0.43 to 0.65, heterogeneity p = 0.021; I-2 54.2%, n = 11 studies). The WMDs for total serum cholesterol (TC) was -1.18 mg/dL (95% CI -1.30 to -1.06, heterogeneity p = 0012; I-2 63.1%, n = 11 studies), 0.126 mg/dL (95% CI 0.02 to 0.22, heterogeneity p = 0.231; I-2 43.2%, n = 11 studies) for HDL-cholesterol, and-0.24 mg/dL (95% CI-0.35 to-0.14, heterogeneity p = 0.562; I-2 23.1%, n = 10 studies) for LDL-cholesterol, and -2.10 mg/dL (95% CI -2.84 to -1.36, heterogeneity p = 0.200; I-2 42.6%, n = 11 studies) fasting blood glucose (FBG) and -0.83% (95% CI -1.08 to -0.57, heterogeneity p = 0.856; I-2 20.9%, n = 11 studies) for HbA1c. These findings were robust in sensitivity analyses. Conclusions: This meta-analysis suggests that therapy with BAS significantly improves HDL-C, LDL-C, and glycemic markers including fasting blood glucose, HbA1c levels, while deteriorating triglyceride levels. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:850 / 857
页数:8
相关论文
共 51 条
[1]   Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin - Glucose and lipid effects [J].
Bays, Harold E. ;
Goldberg, Ronald B. ;
Truitt, Kenneth E. ;
Jones, Michael R. .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (18) :1975-1983
[2]  
Bays Harold E, 2007, Am J Ther, V14, P567, DOI 10.1097/MJT.0b013e31815a69fc
[3]   Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study [J].
Beysen, C. ;
Murphy, E. J. ;
Deines, K. ;
Chan, M. ;
Tsang, E. ;
Glass, A. ;
Turner, S. M. ;
Protasio, J. ;
Riiff, T. ;
Hellerstein, M. K. .
DIABETOLOGIA, 2012, 55 (02) :432-442
[4]  
Brunetti Luigi, 2015, P T, V40, P62
[5]   Effects of dietary calcium supplementation on blood pressure - A meta-analysis of randomized controlled trials [J].
Bucher, HC ;
Cook, RJ ;
Guyatt, GH ;
Lang, JD ;
Cook, DJ ;
Hatala, R ;
Hunt, DL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (13) :1016-1022
[6]   Cholestyramine Reverses Hyperglycemia and Enhances Glucose-Stimulated Glucagon-Like Peptide 1 Release in Zucker Diabetic Fatty Rats [J].
Chen, Lihong ;
McNulty, Judi ;
Anderson, Don ;
Liu, Yaping ;
Nystrom, Christopher ;
Bullard, Sarah ;
Collins, Jon ;
Handlon, Anthony L. ;
Klein, Ryan ;
Grimes, Angela ;
Murray, David ;
Brown, Roger ;
Krull, David ;
Benson, Bill ;
Kleymenova, Elena ;
Remlinger, Katja ;
Young, Andrew ;
Yao, Xiaozhou .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (01) :164-170
[7]   Colesevelam hydrochloride (Cholestagel) - A new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects [J].
Davidson, MH ;
Dillon, MA ;
Gordon, B ;
Jones, P ;
Samuels, J ;
Weiss, S ;
Isaacsohn, J ;
Toth, P ;
Burke, SK .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (16) :1893-1900
[8]   Effect of colesevelam and niacin on low-density lipoprotein cholesterol and glycemic control in subjects with dyslipidemia and impaired fasting glucose [J].
Davidson, Michael H. ;
Rooney, Michael ;
Pollock, Elisabeth ;
Drucker, Joan ;
Choy, Young .
JOURNAL OF CLINICAL LIPIDOLOGY, 2013, 7 (05) :423-432
[9]   Effects of colesevelam HCl on sterol and bile acid excretion in patients with type IIa hypercholesterolemia [J].
Donovan, JM ;
Von Bergmann, K ;
Setchell, KDR ;
Isaacsohn, J ;
Pappu, AS ;
Illingworth, DR ;
Olson, T ;
Burke, SK .
DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (07) :1232-1238
[10]   Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis [J].
Duval, S ;
Tweedie, R .
BIOMETRICS, 2000, 56 (02) :455-463